Bio-Techne (TECH) Other Non Operating Income (2009 - 2026)
Bio-Techne's (TECH) quarterly Other Non Operating Income came in at -$160000.0 in Q1 2026, up 90.66% year-on-year from -$83919.2 in Q1 2025, and up 77.5% quarter-over-quarter from -$711000.0 in Q4 2025.
Bio-Techne (TECH) Other Non Operating Income (2009 - 2026) Analysis & Trends
Bio-Techne's Other Non Operating Income history runs 18 years deep, the most recent figure standing at -$160000.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income rose 90.66% year-over-year to -$160000.0 in Q1 2026; TTM through Mar 2026 was $3.1 million, a 131.81% increase from a year earlier, with the FY2025 full-year figure at $831000.0, up 109.68% from the prior year.
- Other Non Operating Income improved to -$160000.0 in Q1 2026 per TECH's latest filing, from -$711000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $7.2 million in Q1 2022 and bottomed at -$4.9 million in Q2 2024.
- The 5-year median for Other Non Operating Income is -$350000.0 (2023), against an average of $247058.8.
- Biggest YoY gain for Other Non Operating Income was 214.64% in 2025; the steepest drop was 1480.0% in 2025.
- Year by year, Other Non Operating Income stood at -$685000.0 in 2022, then tumbled by 435.77% to -$3.7 million in 2023, then surged by 98.77% to -$45000.0 in 2024, then tumbled by 1480.0% to -$711000.0 in 2025, then soared by 77.5% to -$160000.0 in 2026.
- Per Business Quant, the three latest TECH Other Non Operating Income figures stand at -$160000.0 (Q1 2026), -$711000.0 (Q4 2025), and -$1.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Bio-Techne | 11.19 Bn | 10.98 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -160,000.00 |
| Dec 31, 2025 | -711,000.00 |
| Sep 30, 2025 | -1.67 Mn |
| Jun 30, 2025 | 5.62 Mn |
| Mar 31, 2025 | -1.71 Mn |
| Dec 31, 2024 | -45,000.00 |
| Sep 30, 2024 | -3.03 Mn |
| Jun 30, 2024 | -4.90 Mn |
| Mar 31, 2024 | 335,000.00 |
| Dec 31, 2023 | -3.67 Mn |
| Sep 30, 2023 | -350,000.00 |
| Jun 30, 2023 | 2.49 Mn |
| Mar 31, 2023 | -1.71 Mn |
| Dec 31, 2022 | -685,000.00 |
| Sep 30, 2022 | 4.70 Mn |
| Jun 30, 2022 | 2.52 Mn |
| Mar 31, 2022 | 7.18 Mn |
| Dec 31, 2021 | 26.49 Mn |
| Sep 30, 2021 | 7.38 Mn |
| Jun 30, 2021 | 1.57 Mn |